Goldman Sachs Downgrades Myriad Genetics (MYGN) to Neutral Following SCOTUS Case
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Downgrades Myriad Genetics (MYGN) to Neutral
December 3, 2012 8:06 AM ESTMizuho Securities downgraded Myriad Genetics (NASDAQ: MYGN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $28.72 yesterday, with a 52 week range of $19.21-$31.80.... More
Myriad Genetics (MYGN) Says U.S. Supreme Court to Hear AMP Case
November 30, 2012 4:12 PM ESTMyriad Genetics, Inc. (Nasdaq: MYGN) reported today that the Supreme Court of the United States granted certiorari agreeing to hear the case of The Association for Molecular Pathology, et al., v. Myriad Genetics, Inc., et al (Docket No. 12-398). The Supreme Court... More
High Court to Review Myriad (MYGN) Patent on Genes
November 30, 2012 3:50 PM ESTShares of generic drug maker Myriad Genetics Inc. (Nasdaq: MYGN) experienced volatility on Friday when news broke that the U.S. high court was going decide whether human genes can be patented.
Myriad Genetics holds patents on two genes linked to... More
Myriad Genetics (MYGN) Resumes Trading, SharesDown 4.5%
November 30, 2012 3:25 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) resumes trading, shares down 4.5 percent on the session.... More
Myriad (MYGN) Falls; Generic Drugmakers to Get High Court Review on Patent Suits
November 30, 2012 3:22 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) shares volatile as generic drugmakers will get U.S. high court review on patent suits.... More
Myriad Genetics (MYGN) trading halted for volatility
November 30, 2012 3:20 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) trading halted for volatility.... More
